Skip to main content

US fails to shield humanitarian trade with Iran as sanctions loom

European governments are urging the Trump administration to identify a legal means for their companies to continue to provide food and medicine to Iranians after the Nov. 5 re-imposition of secondary sanctions begins.

Iranians shop at a drugstore at the Nikan hospital in Tehran on September 11, 2018. - Judges at the International Court of Justice in The Hague unanimously ruled Washington should remove barriers to "the free exportation to Iran of medicines and medical devices, food and agricultural commodities" as well as airplane parts. Iran produces 96 percent of the drugs it uses, according to the Syndicate of Iranian Pharmaceutical Industries, but imports more than half the raw materials to make them. (Photo by STRING
Iranians shop at a drugstore at the Nikan hospital in Tehran on Sept. 11, 2018. Judges at the International Court of Justice in The Hague unanimously ruled Washington should remove barriers to 'the free exportation to Iran of medicines and medical devices, food and agricultural commodities' as well as airplane parts. — STRINGER/AFP/Getty Images

European countries seeking to preserve the Iran nuclear deal in the face of resumed US sanctions are urging the Donald Trump administration to clarify how they can continue to legally provide food, medicine and medical devices to Iran.

Humanitarian trade is supposed to be exempt from the sanctions, which go back into full effect on Nov. 5. But with European banks reluctant to finance any transactions with Iran for fear of jeopardizing their much more lucrative US business, it remains unclear how crucial items will continue to flow to the Iranian people.

At an event at the conservative Hudson Institute on Oct. 29, French Ambassador to Washington Gerard Araud said US European allies “are expecting our American friends to make some gestures. For instance, the humanitarian goods. Of course, humanitarian goods are not sanctioned. But the fact is that the banks are so terrified by the sanctions that they don’t want to do anything with Iran.”

Araud added, “There is a strong risk in a few months that there will be a shortage of medicine in Iran if we don’t do something positive to solve this problem.”

SUBSCRIBER EXCLUSIVE

Continue reading this exclusive analysis

Original reporting and analysis unavailable elsewhere. Subscribe to AL-MONITOR to read this story and access everything we publish